Objective: African-American women represent an understudied population in menopause research yet face greater postmenopausal challenges associated with mortality than their white peers. We investigated the effects of a mild-intensity aerobic exercise training program on markers of mortality risk in both premenopausal and postmenopausal African-American women.
W ith the onset of menopause, women face greater metabolic challenges that predispose them to greater mortality risk compared with their premenopausal (pre-MP) years. Most notably, postmenopausal (post-MP) women are more likely to develop metabolic syndrome (MS) and cardiovascular disease (CVD), ultimately resulting in increased mortality. 1<7 A powerful tool in the prevention and treatment of CVD and MS is aerobic exercise training (AEXT). 8<16 However, only a few studies have investigated the effects of AEXT on CVD risk factors in post-MP women in vivo. Findings include beneficial adaptations to AEXT in relation to arterial stiffness, body weight, triglyceride level, total cholesterol level, low-density lipoprotein (LDL) cholesterol level, and intima-media thickness. 17<19 Actual comparisons of adaptation to AEXT between pre-MP and post-MP women are scarce in the literature. Measures in these studies were usually limited to lipid profile markers. Similar improvements in triglyceride, LDL, and total cholesterol levels were found between groups, with high-density lipoprotein (HDL) levels remaining unchanged in both pre-MP and post-MP women. 20, 21 African-American women represent an understudied population in menopause-associated CVD risk factors and their modification. Yet, African-American women inherently have greater risks for CVD, MS, and associated mortality. 22<26 In addition, African-American women reach menopause at a younger age than their white peers, which in itself increases the risks for CVD and mortality. 27<29 Among the few studies that have investigated menopause in African-American women, increased severity of vasomotor symptoms and presence of CVD risk factors, compared with other racial groups, were found. 30, 31 To the best of our knowledge, no in vivo studies have investigated the effects of AEXT on CVD risk factors in this population, let alone compared AEXT adaptations with their pre-MP peers. In addition, this is the first study to investigate the effects of AEXT on several markers of kidney and vascular functions, including endothelial microparticles (EMPs), a novel marker in vascular health and disease in post-MP women. 32, 33 The primary aim of this pilot study was to determine whether a standardized AEXT program similarly benefits a small sample of high-risk post-MP and pre-MP women. We hypothesized that post-MP African-American women would have a blunted exercise response in relation to CVD risk factors, warranting further investigation.
METHODS

Participants
Thirty-five middle-to older-aged (40-75 y) African-American women selected from the Fit4Life study were included in the study and stratified by menopause status. All participants were sedentary (aerobic exercise two or fewer times per week), nondiabetic (fasting blood glucose e125 mg/dL), nonsmokers (Q2 y), and nonhyperlipidemic (total cholesterol e240 mg/dL); had a clinical blood pressure lower than 160/100 mm Hg; had no signs of cardiovascular, renal, or pulmonary disease; and were not taking any lipid-lowering medications or any medications that may affect cardiovascular or renal hemodynamics. Post-MP participants (n = 19) were not taking any hormone therapy. Each participant gave a written informed consent form. The protocol was approved by the Temple University Institutional Review Board.
Screening
After the initial telephone interviews, participants were invited to three consecutive screening visits to determine their eligibility according to the study criteria. The first visit followed a 12-hour fast and included collection of blood and urine samples for blood chemistry analysis and urinalysis by Quest Diagnostics. Glomerular filtration rate (GFR) was estimated using the four-variable Chronic Kidney Disease Epidemiology Collaboration equation. 34 A cardiologistadministered physical examination and a review of health history were performed on the second visit. The third visit required participants to undergo a cycle ergometer echocardiogram stress test to further rule out cardiopulmonary abnormalities and discrepancies in the study sample. In addition, participants_ blood pressures were assessed by measuring seated blood pressures using an aneroid sphygmomanometer (model 11-675D; Omron, Vernon Hills, IL) and by averaging three measures each from three separate visits. During each visit, participants had to rest for 5 minutes before the first measurement. Each consecutive measure was 5 minutes apart.
Internal consistency and reliability (Cronbach_s > = 0.9; mean interitem correlation, 0.75) for both systolic and diastolic blood pressures were determined.
EMP analysis
EMPs were analyzed as previously reported. 35 Briefly, plasma samples were centrifuged twice at 1,500g and 24-C for 20 minutes to obtain cell-free plasma. One hundred microliters of sample was incubated with fluorochrome-labeled antibodies, fixed with 93 KL of 10% formaldehyde, and gently agitated (500 rpm) for 20 minutes at 24-C. Samples were diluted in 500 mL of 0.22-Km double-filtered phosphatebuffered saline and analyzed using a BDLSRII flow cytometer and BD FACSDIVA software (BD Biosciences, San Jose, CA). Labeled events less than 1.0 Km were defined as EMPs and identified with a logarithmic scale for forward scatter signal, side scatter signal, and fluorescent channel. The flow rate was set to medium, and all samples were run for 180 seconds, yielding a mean sample volume of 101 KL per 180 seconds. EMPs were expressed as events per microliter of plasma. EMPs labeled with CD31 + /CD42b j were used to identify EMPs released because of endothelial cell apoptosis, whereas EMPs labeled with CD62E + were used to identify EMPs released because of endothelial cell activation. 33 The interassay and intra-assay coefficients of variation were 15% and 8% for CD62E + and 6% and 8% for CD31 + /CD42b j .
Exercise training intervention
Each participant performed a submaximal graded exercise test using the modified Bruce protocol to determine aerobic fitness levels through continuous measurement of oxygen consumption (VO 2 ) via a metabolic cart (Vmax Encore; SensorMedics, Yorba Linda, CA) to estimate maximal aerobic fitness capacity (VO 2 max). Each test was preceded by flow volume and gas mixture calibration to ensure validity and reproducibility. Participants underwent 6 months of closely supervised AEXT. Initially, participants exercised for 20 minutes at 50% of VO 2 max three times per week. Frequency was maintained, and duration of exercise was increased weekly at 5-minute increments until a total exercise time of 40 minutes was achieved. At this point, exercise intensity was increased from 50% of VO 2 max to 65% of VO 2 max at weekly increments of 5% of VO 2 max. For the remainder of the intervention, participants exercised at this moderate intensity for 40 minutes three times per week. Exercise modes included treadmill walking/jogging, stair stepping, stationary cycling, rowing ergometry, arm ergometry, and elliptical cross-training. Exercise duration and intensity were supervised by study personnel using heart rate monitors and recorded every 10 minutes for the duration of the exercise.
Validity and reliability of measurements: statistical analysis
Data are expressed as mean (SEM). The distribution of each variable was examined using the Shapiro-Wilk test of normality. Nonparametric tests were used when appropriate. For within-group comparisons before and after AEXT, pairedsample tests were used (t test or Wilcoxon signed rank test). For between-group comparisons at the same time points (before or after AEXT), independent-samples tests were performed (t test or Mann-Whitney U test). For correlation analysis, Pearson product-moment correlation coefficient or Spearman_s rank correlation coefficient was determined. Statistical significance was defined as P e 0.05. All statistical analyses were performed using PSAW version 17.0 (SPSS Inc, Chicago, IL). Differences in the number of participants between variables are attributed to issues with participant scheduling, acquisition of blood samples, or assay procedure.
RESULTS
The study group consisted of 16 pre-MP and 19 post-MP African-American women. Summary characteristics for both groups are listed in Table 1 3 , P e 0.05; Fig. 2 ). Markers of late-phase endothelial dysfunction and endothelial cell apoptosis (CD31 + /CD42b j EMPs) were not significantly (Fig. 4) .
DISCUSSION
In summary, our pilot study revealed that mild-intensity AEXT was successful in improving some markers of CVD and mortality in a small sample of post-MP women. However, AEXT was not successful in improving certain other markers of CVD and mortality that the pre-MP group showed improvements in. This may be attributed to the effects of menopauseV and not merely of aging, as evidenced by the lack of correlation of age with most of the other measured variables.
Interestingly, aerobic fitness did not improve in the post-MP group after 6 months of AEXT. It has been previously suggested that post-MP women present abnormalities in the peripheral circulation that could impair aerobic exercise capacity. 36 As such, the lack of improvements in aerobic fitness in the present study may partly be explained by abnormalities in the peripheral circulation. If confirmed in more large-scale randomized controlled trials, the findings might suggest a need for different exercise prescriptions among post-MP women to elicit similar exercise adaptations as in the pre-MP group. This finding should, however, be interpreted with some caution, as the small sample size may have limited our statistical power to detect improvements in aerobic fitness. Nevertheless, we suspect that a lack of statistical power probably did not confound this study finding, as both groups (pre-MP and post-MP women) received the same exercise intervention and this intervention was sufficient to elicit significant improvements in pre-MP women.
It has been previously reported 18 that higher levels of physical activity were associated with lower BMI in post-MP women when compared with nonexercisers. Our findings suggest that AEXT was not sufficient to decrease BMI in the post-MP group. Whether this phenomenon is populationspecific or is caused by the relatively mild exercise intensity of our intervention remains unanswered but again may suggest the need for a higher exercise intensity in the post-MP group to achieve similar results as the pre-MP group.
Total cholesterol and LDL levels were elevated in the post-MP group, as previously reported. 6, 7 We also found that LDL and total cholesterol were correlated with age in the total sample. Therefore, increases in these two lipid markers may not result from the onset of menopause but may simply be a function of age in this population, unlike previous reports. 3, 37 Both LDL and total cholesterol remained unchanged with AEXT in both pre-MP and post-MP women, contrary to previous studies. 20, 21 Moreover, HDL cholesterol did not differ between pre-MP and post-MP women and did not improve with AEXT. Controversy on the matter exists; some studies indicated no improvements in HDL with AEXT in both pre-MP and post-MP women, 20, 21 whereas others reported improvements. 38, 39 The lack of change in HDL, LDL, and total cholesterol in our group could be explained by the relatively mild exercise intensity used in our study. Triglyceride level was the only lipid profile marker that changed in response to AEXT, although there were no differences between pre-MP and post-MP women.
Glucose levels, which did not differ between the groups before the exercise intervention, only improved in the pre-MP group. This may indicate differences in glucose metabolism that are unique to post-MP women, who coincidentally also present a higher risk for diabetes mellitus when compared with their pre-MP peers. 40 Kidney function measured by estimated GFR did not differ between groups, but only the pre-MP group had improved estimated GFR after exercise. This could suggest that AEXT may not be the best method for protecting against progressive declines in kidney function among post-MP women. This is important because African Americans, in particular, have much higher rates of chronic kidney disease (CKD) than their white peers and have been shown to progress more rapidly from the early stages of CKD to more advanced stages. 41, 42 In addition, studies have illustrated the beneficial effects of AEXT on the modification of several CKD risk factors and on the prevention of CKD. 43, 44 However, our data indicate that AEXT may not be sufficient to improve kidney function among post-MP women, as evidenced by the lack of improvement in estimated GFR in this high-risk population.
CD62 + EMPs, a measure of endothelial health status, improved in both the pre-MP group and the post-MP group, and there were no differences between the groups at any time point. Increases in CD62 + EMPs are usually associated with activation of endothelial cells, which is a sign of early-stage endothelial dysfunction, a predecessor of atherosclerosis and hypertension. 32, 33 Conversely, CD31 + /CD42b j EMP levels, a measure of late-stage endothelial dysfunction and apoptosis, only improved in the pre-MP group. These findings, although purely speculative, may suggest that AEXT has the potential to ameliorate early-stage endothelial dysfunction, regardless of menopause status, but may be ineffective in ameliorating later-stage endothelial dysfunction among post-MP women.
CONCLUSIONS
Post-MP African-American women possess a higher CVD risk than their pre-MP peersVonly in relation to lipid profileV before AEXT. Although mild-intensity AEXT does not seem to improve cardiorespiratory fitness, glucose level, LDL level, total cholesterol level, or kidney function in post-MP African-American women, improvements in vascular and endothelial functions may warrant the adoption of a physically active lifestyle to decrease CVD risk after menopause in this population. Further exploration of these findings may be necessary to confirm whether similar exercise effects can be observed in a larger sample. As such, this investigation should only be regarded as a pilot study. Additional lifestyle modifications or perhaps an increased exercise stimulus to address the other CVD risk factors that are unchanged by mild-intensity AEXT should also be explored to potentially further decrease mortality risks after menopause.
